Avid Bioservices Inc (CDMO)

[EYEBUYSTOX]

According to management, they were "very close" to a partner last fall so the basic details surrounding the partnership (i.e. royalties, milestones, etc) should have been agreed to in principle. One reason to delay a partnership now is if PPHM is awaiting news that could increase their leverage in negotiations such as breakthrough designation. I honestly believe that is the case. If, as some speculate, some of the 2nd line NSCLC patients are in remission, that PR could come any time. Based on the options action yesterday I'm hopeful. Look at the Berkshire/Heinz deal. Greed trumps all on the street.